SPring-8 Angstrom Compact free-electron Laser demonstrates shortest wavelength and high peak output

A detailed technical introduction to the SPring-8 Angstrom Compact free-electron Laser (SACLA) appeared online in Nature Photonics. The attention on the world's second XFEL facility comes in response to its record-breaking size and performance: SACLA boasts the shortest wavelength in the world (0.63 Angstroms), an extremely broad wavelength range (0.63 - 3 Angstroms) and a very high peak output of 10 GW. SACLA achieves this performance despite having an overall length of only 700 meters, a fraction of the 2 - 4 km taken up by XFEL facilities in the United States and Europe.

The unique design and original Japanese technologies have enabled SACLA's extremely compact size and its remarkable performance. SACLA is certain to set the standard for XFEL design at new facilities under contemplation across the world.

In March, SACLA was made for use by researchers from within and outside of Japan. The SACLA team continues to work to improve the facility's performance, aiming in the medium-term future to realize the formation of a single-mode laser, and in the longer-term future to develop even more compact XFEL.

Source:

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Study finds microplastics in blood clots, linking them to higher risk of heart attacks and strokes